283 related articles for article (PubMed ID: 28423592)
1. Protective effect of hydrogen sulphide against myocardial hypertrophy in mice.
Shao M; Zhuo C; Jiang R; Chen G; Shan J; Ping J; Tian H; Wang L; Lin C; Hu L
Oncotarget; 2017 Apr; 8(14):22344-22352. PubMed ID: 28423592
[TBL] [Abstract][Full Text] [Related]
2. Antioxidant effects of hydrogen sulfide on left ventricular remodeling in smoking rats are mediated via PI3K/Akt-dependent activation of Nrf2.
Zhou X; Zhao L; Mao J; Huang J; Chen J
Toxicol Sci; 2015 Mar; 144(1):197-203. PubMed ID: 25516494
[TBL] [Abstract][Full Text] [Related]
3. Propofol ameliorates hyperglycemia-induced cardiac hypertrophy and dysfunction via heme oxygenase-1/signal transducer and activator of transcription 3 signaling pathway in rats.
Xu J; Li H; Irwin MG; Xia ZY; Mao X; Lei S; Wong GT; Hung V; Cheung CW; Fang X; Clanachan AS; Xia Z
Crit Care Med; 2014 Aug; 42(8):e583-94. PubMed ID: 24810525
[TBL] [Abstract][Full Text] [Related]
4. Astragaloside IV Exerts a Myocardial Protective Effect against Cardiac Hypertrophy in Rats, Partially via Activating the Nrf2/HO-1 Signaling Pathway.
Nie P; Meng F; Zhang J; Wei X; Shen C
Oxid Med Cell Longev; 2019; 2019():4625912. PubMed ID: 31285785
[TBL] [Abstract][Full Text] [Related]
5. Nitrite Therapy Ameliorates Myocardial Dysfunction via H2S and Nuclear Factor-Erythroid 2-Related Factor 2 (Nrf2)-Dependent Signaling in Chronic Heart Failure.
Donnarumma E; Bhushan S; Bradley JM; Otsuka H; Donnelly EL; Lefer DJ; Islam KN
J Am Heart Assoc; 2016 Jul; 5(8):. PubMed ID: 27473036
[TBL] [Abstract][Full Text] [Related]
6. 5-aminolevulinic acid combined with sodium ferrous citrate ameliorates H2O2-induced cardiomyocyte hypertrophy via activation of the MAPK/Nrf2/HO-1 pathway.
Zhao M; Guo H; Chen J; Fujino M; Ito H; Takahashi K; Abe F; Nakajima M; Tanaka T; Wang J; Huang H; Zheng S; Hei M; Li J; Huang S; Li J; Ma X; Chen Y; Zhao L; Zhuang J; Zhu P; Li XK
Am J Physiol Cell Physiol; 2015 Apr; 308(8):C665-72. PubMed ID: 25652453
[TBL] [Abstract][Full Text] [Related]
7. Sodium Sulfide Attenuates Ischemic-Induced Heart Failure by Enhancing Proteasomal Function in an Nrf2-Dependent Manner.
Shimizu Y; Nicholson CK; Lambert JP; Barr LA; Kuek N; Herszenhaut D; Tan L; Murohara T; Hansen JM; Husain A; Naqvi N; Calvert JW
Circ Heart Fail; 2016 Apr; 9(4):e002368. PubMed ID: 27056879
[TBL] [Abstract][Full Text] [Related]
8. Isorhapontigenin, a new resveratrol analog, attenuates cardiac hypertrophy via blocking signaling transduction pathways.
Li HL; Wang AB; Huang Y; Liu DP; Wei C; Williams GM; Zhang CN; Liu G; Liu YQ; Hao DL; Hui RT; Lin M; Liang CC
Free Radic Biol Med; 2005 Jan; 38(2):243-57. PubMed ID: 15607907
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen Sulfide Improves Myocardial Remodeling via Downregulated Angiotensin Ⅱ/AT1R Pathway in Renovascular Hypertensive Rats.
Liu SY; Duan XC; Jin S; Teng X; Xiao L; Xue HM; Wu YM
Am J Hypertens; 2017 Jan; 30(1):67-74. PubMed ID: 27600580
[TBL] [Abstract][Full Text] [Related]
10. BRD4 blockage alleviates pathological cardiac hypertrophy through the suppression of fibrosis and inflammation via reducing ROS generation.
Zhu W; Wu RD; Lv YG; Liu YM; Huang H; Xu JQ
Biomed Pharmacother; 2020 Jan; 121():109368. PubMed ID: 31707348
[TBL] [Abstract][Full Text] [Related]
11. Peroxiredoxin-1 ameliorates pressure overload-induced cardiac hypertrophy and fibrosis.
Tang C; Yin G; Huang C; Wang H; Gao J; Luo J; Zhang Z; Wang J; Hong J; Chai X
Biomed Pharmacother; 2020 Sep; 129():110357. PubMed ID: 32531679
[TBL] [Abstract][Full Text] [Related]
12. Hyperoside Protects Against Pressure Overload-Induced Cardiac Remodeling via the AKT Signaling Pathway.
Wang X; Liu Y; Xiao L; Li L; Zhao X; Yang L; Chen N; Gao L; Zhang J
Cell Physiol Biochem; 2018; 51(2):827-841. PubMed ID: 30466089
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of Nrf2/HO-1 and inhibition of TGF-β1/Smad2/3 signaling axis by daphnetin alleviates transverse aortic constriction-induced cardiac remodeling in mice.
Syed AM; Kundu S; Ram C; Kulhari U; Kumar A; Mugale MN; Mohapatra P; Murty US; Sahu BD
Free Radic Biol Med; 2022 Jun; 186():17-30. PubMed ID: 35513128
[TBL] [Abstract][Full Text] [Related]
14. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner.
Meng G; Liu J; Liu S; Song Q; Liu L; Xie L; Han Y; Ji Y
Br J Pharmacol; 2018 Apr; 175(8):1126-1145. PubMed ID: 28503736
[TBL] [Abstract][Full Text] [Related]
15. Pinocembrin ameliorates post-infarct heart failure through activation of Nrf2/HO-1 signaling pathway.
Chen X; Wan W; Guo Y; Ye T; Fo Y; Sun Y; Qu C; Yang B; Zhang C
Mol Med; 2021 Sep; 27(1):100. PubMed ID: 34488618
[TBL] [Abstract][Full Text] [Related]
16. Zingerone attenuates aortic banding-induced cardiac remodelling via activating the eNOS/Nrf2 pathway.
Liu C; Wu QQ; Cai ZL; Xie SY; Duan MX; Xie QW; Yuan Y; Deng W; Tang QZ
J Cell Mol Med; 2019 Sep; 23(9):6466-6478. PubMed ID: 31293067
[TBL] [Abstract][Full Text] [Related]
17. Nrf2 protects against maladaptive cardiac responses to hemodynamic stress.
Li J; Ichikawa T; Villacorta L; Janicki JS; Brower GL; Yamamoto M; Cui T
Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1843-50. PubMed ID: 19592468
[TBL] [Abstract][Full Text] [Related]
18. Azilsartan ameliorates ventricular hypertrophy in rats suffering from pressure overload-induced cardiac hypertrophy by activating the Keap1-Nrf2 signalling pathway.
Hou N; Li LR; Shi YY; Yuan WC; Zhao GJ; Liu XW; Cai SA; Huang Y; Zhan HX; Pan WB; Luo CF
J Pharm Pharmacol; 2021 Dec; 73(12):1715-1725. PubMed ID: 34343333
[TBL] [Abstract][Full Text] [Related]
19. Rosuvastatin suppresses atrial tachycardia-induced cellular remodeling via Akt/Nrf2/heme oxygenase-1 pathway.
Yeh YH; Kuo CT; Chang GJ; Chen YH; Lai YJ; Cheng ML; Chen WJ
J Mol Cell Cardiol; 2015 May; 82():84-92. PubMed ID: 25771143
[TBL] [Abstract][Full Text] [Related]
20. The protective effects of endogenous hydrogen sulfide modulator, S-propargyl-cysteine, on high glucose-induced apoptosis in cardiomyocytes: A novel mechanism mediated by the activation of Nrf2.
Yang H; Mao Y; Tan B; Luo S; Zhu Y
Eur J Pharmacol; 2015 Aug; 761():135-43. PubMed ID: 25979858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
